Apply to Graduate School | Library | Jobs & Volunteers | Visitor Information | Department Index | News      
The Department of Microbiology and Immunology at Wake Forest University

 

Ryan Michalek

B.S.  University of Connecticut  2003

 

Advisor:

Jason Grayson

e-mail:

rmichale@wfubmc.edu

“Choosing a graduate school is one of the most difficult decisions I have ever had to make, but Wake Forest University simplified the process by demonstrating what higher-level education should be. The only asset greater than the science of the Microbiology and Immunology department is t teaching. The close mentor/trainee relationship highlights the professors' commitment to learning and to the students' evolution as a scientist. This commitment coupled with the latest technology and research, great colleagues, and an expanding city make Wake Forest University an easy choice.”

Understanding the Role of Reactive Oxygen Intermediates(ROI) in Naïve CD8+ T cell Activation and Proliferation

Reactive Oxygen Intermediates(ROI) are formed by the catalytic conversion of molecular oxygen to free radicals. These metabolic byproducts have been associated with all forms of macromolecule damage and have been implicated in aging, cancer, and Alzheimer’s disease. In contrast, other studies have demonstrated a beneficial role for ROI in the respiratory burst of neutrophils and in the signal transduction cascades of PDGF(platelet-derived growth factor), EGF(epidermal growth factor), and angiotensin II.

In vivo studies with the antioxidant MnTBAP (Mn[III]tetrakis[4-benzoic acid]porphyrin chloride) have shown that during an acute LCMV-Armstrong infection, drug treatment decreases the expansion and contraction of CD8+ T cells. It has also been demonstrated that naïve CD8+ T cells quickly produce superoxide and hydrogen peroxide upon peptide stimulation. Regulating ROI production in T cells may allow us to control their activation, proliferation, and differentiation. One potential medical application involves inhibiting the proliferation of autoimmune cells in disorders such as lupus.

Revised: 12-Jun-08